News

ProKidney Corp. Prepares for Major Healthcare Conferences

ProKidney Corp. Prepares for Major Healthcare Conferences

ProKidney Set for Upcoming Healthcare Conferences

WINSTON-SALEM, N.C. — ProKidney Corp. (Nasdaq: PROK), a leader in the clinical-stage cellular therapeutics field, is excited to announce that its senior management will be participating in two significant healthcare conferences this September. These conferences are an excellent opportunity for ProKidney to showcase its advancements and innovations in treating chronic kidney disease (CKD).

Citi Biopharma Back to School Conference

One of the first events on the agenda is the Citi Biopharma Back to School Conference. This event is scheduled for September 3 and will be hosted in Boston. The format will be a fireside chat, offering an intimate setting where discussions can easily flow. ProKidney’s engagement in this conference demonstrates its commitment to sharing insights and developments with key stakeholders in the healthcare community.

Event Details

The Citi Biopharma Conference will begin at 10:30 AM ET. Attendees can follow the discussion and gain valuable insights into the company's research and future plans. The session can be accessed through the Investor Relations section of ProKidney's website.

Morgan Stanley Global Healthcare Conference

Following the Citi event, ProKidney will participate in the Morgan Stanley Global Healthcare Conference, happening on September 8 in New York. This major conference is known for gathering prominent healthcare voices, and ProKidney is honored to be part of it.

What to Expect

Another fireside chat format will facilitate open discussions at 7:00 AM ET. ProKidney's executives will share key updates about the company's ongoing Phase 3 REGEN-006 study, highlighting the potential benefits of their leading product candidate, rilparencel. Attendees can expect in-depth conversation about ProKidney's innovations and how they aim to significantly improve the treatment landscape for CKD patients.

Access to Live Webcasts

For those interested in following the live coverage, both sessions will be available via webcast on ProKidney's website. This provides a perfect avenue for investors and interested parties to stay informed about the latest developments in the field of chronic kidney disease.

About ProKidney Corp.

ProKidney has positioned itself as a pioneer in treating chronic kidney disease through advanced cellular therapy innovations. Established in 2015, ProKidney's dedication stems from over a decade of extensive research. Its primary product, rilparencel, is celebrated for being the first of its kind and comes with proprietary and patented technology. This cellular therapy is currently undergoing evaluation in the ongoing Phase 3 trial, showing promise in preserving kidney function for advanced CKD patients, especially those alongside type 2 diabetes.

Further Information

Investors or professionals looking for more details about ProKidney executive insights or potential collaborations are encouraged to reach out through the official channels provided on the website.

Frequently Asked Questions

What is ProKidney Corp. known for?

ProKidney Corp. focuses on developing innovative therapies for chronic kidney disease, particularly through cellular therapeutic advancements.

When will ProKidney participate in the upcoming conferences?

ProKidney will participate in the Citi Biopharma Back to School Conference on September 3 and the Morgan Stanley Global Healthcare Conference on September 8.

What is rilparencel?

Rilparencel is ProKidney’s leading product candidate, recognized as a first-in-class cellular therapy aimed at preserving kidney function in patients with advanced CKD.

How can investors learn more about ProKidney?

Investors can visit ProKidney's website, specifically the Investor Relations section, for updates and access to webcasts of upcoming conference sessions.

Who can be contacted for investor relations?

For investor inquiries, Ethan Holdaway from ProKidney and Daniel Ferry from LifeSci Advisors are available for contact through their respective emails provided in the announcements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 6

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 5

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 9

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 4

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Dynamics: Are Insiders Anticipating Economic Decline?

Updated Category News Views 55

Market Dynamics: Are Insiders Anticipating Economic Decline? The trading landscape has undergone a shift from the conditions that characterized the last twenty years. With increasing interest rates dominating the financial scene, one might expect that equity valuations would take a hit. Understanding the Impact of Higher Interest Rates Contrary to expectations, we haven't...

Continue Reading
Elon Musk's Vision: Launching Starship 24 Times in 24 Hours

Updated Category News Views 270

Elon Musk's Ambitious Prediction for SpaceX Elon Musk has continuously pushed the boundaries of what is possible, and his latest forecast introduces a remarkable benchmark for SpaceX. After witnessing SpaceX successfully complete three Falcon launches within a mere 51 hours, Musk joined the conversation on X, where users compared the frequency of launches to airline-level...

Continue Reading
Wingstop's Exciting BOGO Tender Offer Brings Flavor to Fans

Updated Category News Views 432

Wingstop's Newest Promotion: Buy-One-Get-One Free Tenders Double the tenders, double the flavor Wingstop, known for its mouthwatering chicken dishes, is launching an irresistible promotion: for a limited time, customers can enjoy Buy-One-Get-One free (BOGO) 4-piece tenders. This new drop invites fans to double their enjoyment with Wingstop's signature tenders, which have...

Continue Reading
Experience the Enchantment of Sleep with Good Morning Cat

Updated Category News Views 187

Experience the Magic of Bedtime with Good Morning Cat Parents everywhere are discovering the joy of a new children's book that's perfect for winding down after a busy day. This delightful eBook, titled "Good Morning Cat, Good Night Mouse", features the internet’s beloved feline sensation who has captured the hearts of families worldwide. The charming story is now...

Continue Reading
Teleflex: Anticipating Earnings and Market Insights Ahead

Updated Category News Views 82

Teleflex: Anticipating Earnings and Market Insights Ahead Teleflex (NYSE: TFX) is preparing to release its quarterly earnings report. Investors are keenly focused on this upcoming announcement, particularly eager to see if the company will surpass earnings estimates. Analysts predict an earnings per share (EPS) of $3.39, reflecting optimism regarding Teleflex's...

Continue Reading